Positions
Position Company Period
Chief Financial Officer, Executive Vice President Onyx Pharmaceuticals Inc Jan. 5, 2009 -
Independent Director Sunesis Pharmaceuticals Inc May 1, 2005 -
Independent Director Ultragenyx Pharmaceutical Inc Feb. 6, 2014 -
Independent Director Atara Biotherapeutics Inc March 1, 2014 -
Independent Director Crinetics Pharmaceuticals Inc Feb. 1, 2018 -
Independent Director MacroGenics Inc March 6, 2014 - May 14, 2020
Independent Director Dermira Inc April 1, 2014 - Feb. 20, 2020
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2024-03-22 2024-03-20
PS Planned sale
17,500 -48.6%
45.50
796,250 USD 		17,500 -48.6% 45.50 796,250 USD
2024-03-22 2024-03-20
PS Planned sale
17,500 -48.6%
43.58
762,650 USD 		17,500 -48.6% 43.58 762,650 USD
2024-03-22 2024-03-20
PS Planned sale
12,500 -40.3%
43.57
544,625 USD 		12,500 -40.3% 43.57 544,625 USD
2024-03-22 2024-03-20
PS Planned sale
12,500 -40.3%
43.57
544,625 USD 		12,500 -40.3% 43.57 544,625 USD
2024-03-11 2024-03-07
S Sale
7,500 -33.5%
50.88
381,600 USD 		7,500 -33.5% 50.88 381,600 USD
2024-03-11 2024-03-07
S Sale
2,145 -8.8%
50.85
109,073 USD 		2,145 -8.8% 50.85 109,073 USD
2024-03-11 2024-03-07
S Sale
2,550 -9.4%
50.89
129,770 USD 		2,550 -9.4% 50.89 129,770 USD
2021-11-05 2021-11-04
PS Planned sale
13,354 -29.8%
19.50
260,403 USD 		13,354 -29.8% 19.50 260,403 USD
2021-11-03 2021-11-01
S Sale
8,954 -41.7%
25.50
228,327 USD 		8,954 -41.7% 25.50 228,327 USD
2021-07-13 2021-07-12
S Sale
5,000 -28.5%
20.71
103,550 USD 		5,000 -28.5% 20.71 103,550 USD
2020-07-08 2020-07-06
PS Planned sale
6,181 -31.3%
90.00
556,290 USD 		6,181 -31.3% 90.00 556,290 USD
2020-07-06 2020-07-01
PS Planned sale
5,000 -27.0%
85.00
425,000 USD 		5,000 -27.0% 85.00 425,000 USD
2020-05-19 2020-05-18
PS Planned sale
1,875 -14.6%
75.00
140,625 USD 		1,875 -14.6% 75.00 140,625 USD
2020-04-24 2020-04-22
PS Planned sale
1,875 -12.7%
65.00
121,875 USD 		1,875 -12.7% 65.00 121,875 USD
2019-09-16 2019-09-12
US Dermira Inc (DERM)
S Sale
6,000 -35.2%
8.77
52,636 USD 		6,000 -35.2% 8.77 52,636 USD
2019-02-08 2019-02-06
PS Planned sale
6,924 -93.3%
29.38
203,427 USD 		6,924 -93.3% 29.38 203,427 USD